<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32756522</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>15</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>03</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Passive Transfer of Sera from ALS Patients with Identified Mutations Evokes an Increased Synaptic Vesicle Number and Elevation of Calcium Levels in Motor Axon Terminals, Similar to Sera from Sporadic Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5566</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21155566</ELocationID><Abstract><AbstractText>Previously, we demonstrated increased calcium levels and synaptic vesicle densities in the motor axon terminals (MATs) of sporadic amyotrophic lateral sclerosis (ALS) patients. Such alterations could be conferred to mice with an intraperitoneal injection of sera from these patients or with purified immunoglobulin G. Later, we confirmed the presence of similar alterations in the superoxide dismutase 1 G93A transgenic mouse strain model of familial ALS. These consistent observations suggested that calcium plays a central role in the pathomechanism of ALS. This may be further reinforced by completing a similar analytical study of the MATs of ALS patients with identified mutations. However, due to the low yield of muscle biopsy samples containing MATs, and the low incidence of ALS patients with the identified mutations, these examinations are not technically feasible. Alternatively, a passive transfer of sera from ALS patients with known mutations was used, and the MATs of the inoculated mice were tested for alterations in their calcium homeostasis and synaptic activity. Patients with 11 different ALS-related mutations participated in the study. Intraperitoneal injection of sera from these patients on two consecutive days resulted in elevated intracellular calcium levels and increased vesicle densities in the MATs of mice, which is comparable to the effect of the passive transfer from sporadic patients. Our results support the idea that the pathomechanism underlying the identical manifestation of the disease with or without identified mutations is based on a common final pathway, in which increasing calcium levels play a central role.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meszl&#xe9;nyi</LastName><ForeName>Val&#xe9;ria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Biological Research Centre, Institute of Biophysics, 62 Temesv&#xe1;ri krt., H-6726 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foundation for the Future of Biomedical Sciences in Szeged, Szeged Scientists Academy, 15 Lechner t&#xe9;r, H-6721 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patai</LastName><ForeName>Roland</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5302-2815</Identifier><AffiliationInfo><Affiliation>Biological Research Centre, Institute of Biophysics, 62 Temesv&#xe1;ri krt., H-6726 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polg&#xe1;r</LastName><ForeName>Tam&#xe1;s F</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Biological Research Centre, Institute of Biophysics, 62 Temesv&#xe1;ri krt., H-6726 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N&#xf3;gr&#xe1;di</LastName><ForeName>Bern&#xe1;t</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-8643-0367</Identifier><AffiliationInfo><Affiliation>Biological Research Centre, Institute of Biophysics, 62 Temesv&#xe1;ri krt., H-6726 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foundation for the Future of Biomedical Sciences in Szeged, Szeged Scientists Academy, 15 Lechner t&#xe9;r, H-6721 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xf6;rm&#xf6;czy</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Biological Research Centre, Institute of Biophysics, 62 Temesv&#xe1;ri krt., H-6726 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krist&#xf3;f</LastName><ForeName>Rebeka</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Biological Research Centre, Institute of Biophysics, 62 Temesv&#xe1;ri krt., H-6726 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spis&#xe1;k</LastName><ForeName>Krisztina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Biological Research Centre, Institute of Biophysics, 62 Temesv&#xe1;ri krt., H-6726 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripolszki</LastName><ForeName>Korn&#xe9;lia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, University of Szeged, 4/B Sz&#x151;kefalvi-Nagy B&#xe9;la u., H-6720 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sz&#xe9;ll</LastName><ForeName>M&#xe1;rta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, University of Szeged, 4/B Sz&#x151;kefalvi-Nagy B&#xe9;la u., H-6720 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dermatological Research Group, University of Szeged, Hungarian Academy of Sciences, 4/B Sz&#x151;kefalvi-Nagy B&#xe9;la u., H-6720 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ob&#xe1;l</LastName><ForeName>Izabella</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, Aalborg University Hospital, 15 Skovvej Sdr., DK-9000 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Szeged, 6 Semmelweis u., H-6725 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engelhardt</LastName><ForeName>J&#xf3;zsef I</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Szeged, 6 Semmelweis u., H-6725 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sikl&#xf3;s</LastName><ForeName>L&#xe1;szl&#xf3;</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Biological Research Centre, Institute of Biophysics, 62 Temesv&#xe1;ri krt., H-6726 Szeged, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GINOP-2.3.2-15-2016-00001</GrantID><Agency>Nemzeti Kutat&#xe1;si Fejleszt&#xe9;si &#xe9;s Innov&#xe1;ci&#xf3;s Hivatal</Agency><Country/></Grant><Grant><GrantID>GINOP-2.3.2-15-2016-00034</GrantID><Agency>Nemzeti Kutat&#xe1;si Fejleszt&#xe9;si &#xe9;s Innov&#xe1;ci&#xf3;s Hivatal</Agency><Country/></Grant><Grant><GrantID>GINOP-2.3.3.-15-2016-00001</GrantID><Agency>Nemzeti Kutat&#xe1;si Fejleszt&#xe9;si &#xe9;s Innov&#xe1;ci&#xf3;s Hivatal</Agency><Country/></Grant><Grant><GrantID>EMMI: 11136-2/2019/FIRFIN</GrantID><Agency>Emberi Eroforr&#xe1;sok Miniszt&#xe9;riuma</Agency><Country/></Grant><Grant><GrantID>NTP-NFT&#xd6;-18-B-208</GrantID><Agency>Emberi Eroforr&#xe1;sok Miniszt&#xe9;riuma</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C109415">SOD1 G93A protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017729" MajorTopicYN="N">Presynaptic Terminals</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013572" MajorTopicYN="N">Synaptic Vesicles</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">C9ORF72 mutation</Keyword><Keyword MajorTopicYN="N">SOD1 mutation</Keyword><Keyword MajorTopicYN="N">intracellular calcium</Keyword><Keyword MajorTopicYN="N">passive transfer</Keyword><Keyword MajorTopicYN="N">synaptic vesicles</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32756522</ArticleId><ArticleId IdType="pmc">PMC7432249</ArticleId><ArticleId IdType="doi">10.3390/ijms21155566</ArticleId><ArticleId IdType="pii">ijms21155566</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N. Eng. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber S.C., Shaw P.J. Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target. Free Radic. Biol. Med. 2010;48:629&#x2013;641. doi: 10.1016/j.freeradbiomed.2009.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.11.018</ArticleId><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurland L.T., Mulder D.W. Epidemiologic investigations of amyotrophic lateral sclerosis. 2. Familial aggregations indicative of dominant inheritance. II. Neurology. 1955;5:249&#x2013;268. doi: 10.1212/WNL.5.4.249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.5.4.249</ArticleId><ArticleId IdType="pubmed">14370376</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Hardiman O., Benatar M., Brooks B.R., Chio A., de Carvalho M., Ince P.G., Lin C., Miller R.G., Mitsumoto H., et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013;12:310&#x2013;322. doi: 10.1016/S1474-4422(13)70036-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70036-X</ArticleId><ArticleId IdType="pmc">PMC4565161</ArticleId><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2014;10:661&#x2013;670. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J., Dawson T.M., Dawson V.L. Cell Death Mechanisms of Neurodegeneration. Adv. Neurobiol. 2017;15:403&#x2013;425. doi: 10.1007/978-3-319-57193-5_16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-57193-5_16</ArticleId><ArticleId IdType="pubmed">28674991</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik A.R., Willnow T.E. Excitatory Amino Acid Transporters in Physiology and Disorders of the Central Nervous System. Int. J. Mol. Sci. 2019;20:5671. doi: 10.3390/ijms20225671.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20225671</ArticleId><ArticleId IdType="pmc">PMC6888459</ArticleId><ArticleId IdType="pubmed">31726793</ArticleId></ArticleIdList></Reference><Reference><Citation>Bano D., Ankarcrona M. Beyond the critical point: An overview of excitotoxicity, calcium overload and the downstream consequences. Neurosci. Lett. 2018;663:79&#x2013;85. doi: 10.1016/j.neulet.2017.08.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.08.048</ArticleId><ArticleId IdType="pubmed">28843346</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A., Kukreti R., Saso L., Kukreti S. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules. 2019;24:1583. doi: 10.3390/molecules24081583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24081583</ArticleId><ArticleId IdType="pmc">PMC6514564</ArticleId><ArticleId IdType="pubmed">31013638</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh E., Devasahayam G. Neurodegeneration by oxidative stress: A review on prospective use of small molecules for neuroprotection. Mol. Biol. Rep. 2020:1&#x2013;8. doi: 10.1007/s11033-020-05354-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-020-05354-1</ArticleId><ArticleId IdType="pubmed">32162127</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaribeygi H., Panahi Y., Javadi B., Sahebkar A. The Underlying Role of Oxidative Stress in Neurodegeneration: A Mechanistic Review. CNS Neurol. Disord. Drug Targets. 2018;17:207&#x2013;215. doi: 10.2174/1871527317666180425122557.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527317666180425122557</ArticleId><ArticleId IdType="pubmed">29692267</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R.L., Soeters M.R., W&#xfc;st R., Houtkooper R.H. Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease. Endocr. Rev. 2018;39:489&#x2013;517. doi: 10.1210/er.2017-00211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2017-00211</ArticleId><ArticleId IdType="pmc">PMC6093334</ArticleId><ArticleId IdType="pubmed">29697773</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W., Zhao D., Shah S., Zhang X., Lai M., Yang D., Wu X., Guan Z., Li J., Zhao H., et al. OPA1 overexpression ameliorates mitochondrial cristae remodeling, mitochondrial dysfunction, and neuronal apoptosis in prion diseases. Cell Death Dis. 2019;10:710. doi: 10.1038/s41419-019-1953-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1953-y</ArticleId><ArticleId IdType="pmc">PMC6760175</ArticleId><ArticleId IdType="pubmed">31551424</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickman S., Izzy S., Sen P., Morsett L., El Khoury J. Microglia in neurodegeneration. Nat. Neurosci. 2018;21:1359&#x2013;1369. doi: 10.1038/s41593-018-0242-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0242-x</ArticleId><ArticleId IdType="pmc">PMC6817969</ArticleId><ArticleId IdType="pubmed">30258234</ArticleId></ArticleIdList></Reference><Reference><Citation>Ob&#xe1;l I., N&#xf3;gr&#xe1;di B., Meszl&#xe9;nyi V., Patai R., Ricken G., Kovacs G.G., Tripolszki K., Sz&#xe9;ll M., Sikl&#xf3;s L., Engelhardt J.I. Experimental Motor Neuron Disease Induced in Mice with Long-Term Repeated Intraperitoneal Injections of Serum from ALS Patients. Int. J. Mol. Sci. 2019;20:2573. doi: 10.3390/ijms20102573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20102573</ArticleId><ArticleId IdType="pmc">PMC6566871</ArticleId><ArticleId IdType="pubmed">31130623</ArticleId></ArticleIdList></Reference><Reference><Citation>Voet S., Srinivasan S., Lamkanfi M., van Loo G. Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol. Med. 2019;11:e10248. doi: 10.15252/emmm.201810248.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201810248</ArticleId><ArticleId IdType="pmc">PMC6554670</ArticleId><ArticleId IdType="pubmed">31015277</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezprozvanny I. Calcium signaling and neurodegenerative diseases. Trends Mol. Med. 2009;15:89&#x2013;100. doi: 10.1016/j.molmed.2009.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2009.01.001</ArticleId><ArticleId IdType="pmc">PMC3226745</ArticleId><ArticleId IdType="pubmed">19230774</ArticleId></ArticleIdList></Reference><Reference><Citation>Enders M., Heider T., Ludwig A., Kuerten S. Strategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium. Int. J. Mol. Sci. 2020;21:1663. doi: 10.3390/ijms21051663.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21051663</ArticleId><ArticleId IdType="pmc">PMC7084497</ArticleId><ArticleId IdType="pubmed">32121306</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaser T., Arnaud Sampaio V.F., Lameu C., Ulrich H. Calcium signalling: A common target in neurological disorders and neurogenesis. Semin. Cell Dev. Biol. 2019;95:25&#x2013;33. doi: 10.1016/j.semcdb.2018.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2018.12.002</ArticleId><ArticleId IdType="pubmed">30529426</ArticleId></ArticleIdList></Reference><Reference><Citation>Pchitskaya E., Popugaeva E., Bezprozvanny I. Calcium signaling and molecular mechanisms underlying neurodegenerative diseases. Cell Calcium. 2018;70:87&#x2013;94. doi: 10.1016/j.ceca.2017.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2017.06.008</ArticleId><ArticleId IdType="pmc">PMC5748019</ArticleId><ArticleId IdType="pubmed">28728834</ArticleId></ArticleIdList></Reference><Reference><Citation>Ureshino R.P., Erustes A.G., Bassani T.B., Wachilewski P., Guarache G.C., Nascimento A.C., Costa A.J., Smaili S.S., Pereira G. The Interplay between Ca2+ Signaling Pathways and Neurodegeneration. Int. J. Mol. Sci. 2019;20:6004. doi: 10.3390/ijms20236004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20236004</ArticleId><ArticleId IdType="pmc">PMC6928941</ArticleId><ArticleId IdType="pubmed">31795242</ArticleId></ArticleIdList></Reference><Reference><Citation>Belsh J.M., Schiffman P.L. The amyotrophic lateral sclerosis (ALS) patient perspective on misdiagnosis and its repercussions. J. Neurol. Sci. 1996;139:110&#x2013;116. doi: 10.1016/0022-510X(96)00088-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(96)00088-3</ArticleId><ArticleId IdType="pubmed">8899669</ArticleId></ArticleIdList></Reference><Reference><Citation>Patai R., N&#xf3;gr&#xe1;di B., Engelhardt J.I., Sikl&#xf3;s L. Calcium in the pathomechanism of amyotrophic lateral sclerosis&#x2014;Taking center stage? Biochem. Biophys. Res. Commun. 2017;483:1031&#x2013;1039. doi: 10.1016/j.bbrc.2016.08.089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.08.089</ArticleId><ArticleId IdType="pubmed">27545602</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikl&#xf3;s L., Engelhardt J., Harati Y., Smith R.G., Jo&#xf3; F., Appel S.H. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann. Neurol. 1996;39:203&#x2013;216. doi: 10.1002/ana.410390210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410390210</ArticleId><ArticleId IdType="pubmed">8967752</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E., Fang F. Epidemiology of amyotrophic lateral sclerosis: An update of recent literature. Curr. Opin. Neurol. 2019;32:771&#x2013;776. doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt J.I., Sikl&#xf3;s L., K&#xf6;m&#xfc;ves L., Smith R.G., Appel S.H. Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons. Synapse. 1995;20:185&#x2013;199. doi: 10.1002/syn.890200302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/syn.890200302</ArticleId><ArticleId IdType="pubmed">7570350</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattler R., Tymianski M. Molecular mechanisms of calcium-dependent excitotoxicity. J. Mol. Med. 2000;78:3&#x2013;13. doi: 10.1007/s001090000077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001090000077</ArticleId><ArticleId IdType="pubmed">10759025</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi D.W., Maulucci-Gedde M., Kriegstein A.R. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 1987;7:357&#x2013;368. doi: 10.1523/JNEUROSCI.07-02-00357.1987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.07-02-00357.1987</ArticleId><ArticleId IdType="pmc">PMC6568898</ArticleId><ArticleId IdType="pubmed">2880937</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1:623&#x2013;634. doi: 10.1016/0896-6273(88)90162-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(88)90162-6</ArticleId><ArticleId IdType="pubmed">2908446</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi D.W. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci. Lett. 1985;58:293&#x2013;297. doi: 10.1016/0304-3940(85)90069-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(85)90069-2</ArticleId><ArticleId IdType="pubmed">2413399</ArticleId></ArticleIdList></Reference><Reference><Citation>Arundine M., Tymianski M. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium. 2003;34:325&#x2013;337. doi: 10.1016/S0143-4160(03)00141-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0143-4160(03)00141-6</ArticleId><ArticleId IdType="pubmed">12909079</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez J., Alvarez-Illera P., Garc&#xed;a-Casas P., Fonteriz R.I., Montero M. The Role of Ca2+ Signaling in Aging and Neurodegeneration: Insights from Caenorhabditis elegans Models. Cells. 2020;9:204. doi: 10.3390/cells9010204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9010204</ArticleId><ArticleId IdType="pmc">PMC7016793</ArticleId><ArticleId IdType="pubmed">31947609</ArticleId></ArticleIdList></Reference><Reference><Citation>Berridge M.J. Calcium hypothesis of Alzheimer&#x2019;s disease. Pflugers Archiv. 2010;459:441&#x2013;449. doi: 10.1007/s00424-009-0736-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-009-0736-1</ArticleId><ArticleId IdType="pubmed">19795132</ArticleId></ArticleIdList></Reference><Reference><Citation>Betzer C., Jensen P.H. Reduced Cytosolic Calcium as an Early Decisive Cellular State in Parkinson&#x2019;s Disease and Synucleinopathies. Front. Neurosci. 2018;12:819. doi: 10.3389/fnins.2018.00819.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00819</ArticleId><ArticleId IdType="pmc">PMC6232531</ArticleId><ArticleId IdType="pubmed">30459551</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosskreutz J., Van Den Bosch L., Keller B.U. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium. 2010;47:165&#x2013;174. doi: 10.1016/j.ceca.2009.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2009.12.002</ArticleId><ArticleId IdType="pubmed">20116097</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zheng W. Ca2+ homeostasis dysregulation in Alzheimer&#x2019;s disease: A focus on plasma membrane and cell organelles. FASEB J. 2019;33:6697&#x2013;6712. doi: 10.1096/fj.201801751R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201801751R</ArticleId><ArticleId IdType="pubmed">30848934</ArticleId></ArticleIdList></Reference><Reference><Citation>von Lewinski F., Fuchs J., Vanselow B.K., Keller B.U. Low Ca2+ buffering in hypoglossal motoneurons of mutant SOD1 (G93A) mice. Neurosci. Lett. 2008;445:224&#x2013;228. doi: 10.1016/j.neulet.2008.08.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2008.08.084</ArticleId><ArticleId IdType="pubmed">18782598</ArticleId></ArticleIdList></Reference><Reference><Citation>von Lewinski F., Keller B.U. Ca2+, mitochondria and selective motoneuron vulnerability: Implications for ALS. Trends Neurosci. 2005;28:494&#x2013;500. doi: 10.1016/j.tins.2005.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2005.07.001</ArticleId><ArticleId IdType="pubmed">16026864</ArticleId></ArticleIdList></Reference><Reference><Citation>May C., Nordhoff E., Casjens S., Turewicz M., Eisenacher M., Gold R., Br&#xfc;ning T., Pesch B., Stephan C., Woitalla D., et al. Highly immunoreactive IgG antibodies directed against a set of twenty human proteins in the sera of patients with amyotrophic lateral sclerosis identified by protein array. PLoS ONE. 2014;9:e89596. doi: 10.1371/journal.pone.0089596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089596</ArticleId><ArticleId IdType="pmc">PMC3935926</ArticleId><ArticleId IdType="pubmed">24586901</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullen A.H., Humphreys P. Ultrastructural analysis of spinal motoneurones from mice treated with IgG from ALS patients, healthy individuals, or disease controls. J. Neurol. Sci. 2000;180:35&#x2013;45. doi: 10.1016/S0022-510X(00)00427-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(00)00427-5</ArticleId><ArticleId IdType="pubmed">11090862</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullen A.H., Demestre M., Howard R.S., Orrell R.W. Passive transfer of purified IgG from patients with amyotrophic lateral sclerosis to mice results in degeneration of motor neurons accompanied by Ca2+ enhancement. Acta Neuropathol. 2004;107:35&#x2013;46. doi: 10.1007/s00401-003-0777-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-003-0777-z</ArticleId><ArticleId IdType="pubmed">14551798</ArticleId></ArticleIdList></Reference><Reference><Citation>Demestre M., Pullen A., Orrell R.W., Orth M. ALS-IgG-induced selective motor neurone apoptosis in rat mixed primary spinal cord cultures. J. Neurochem. 2005;94:268&#x2013;275. doi: 10.1111/j.1471-4159.2005.03184.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03184.x</ArticleId><ArticleId IdType="pubmed">15953369</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R.G., Hamilton S., Hofmann F., Schneider T., Nastainczyk W., Birnbaumer L., Stefani E., Appel S.H. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N. Engl. J. Med. 1992;327:1721&#x2013;1728. doi: 10.1056/NEJM199212103272405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199212103272405</ArticleId><ArticleId IdType="pubmed">1331790</ArticleId></ArticleIdList></Reference><Reference><Citation>Delbono O., Garc&#xed;a J., Appel S.H., Stefani E. IgG from amyotrophic lateral sclerosis affects tubular calcium channels of skeletal muscle. Am. J. Physiol. 1991;260:C1347&#x2013;C1351. doi: 10.1152/ajpcell.1991.260.6.C1347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.1991.260.6.C1347</ArticleId><ArticleId IdType="pubmed">1647668</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnelli V., Sawada T., Delbono O., Smith R.G., Appel S.H., Stefani E. The action of amyotrophic lateral sclerosis immunoglobulins on mammalian single skeletal muscle Ca2+ channels. J. Physiol. 1993;461:103&#x2013;118. doi: 10.1113/jphysiol.1993.sp019504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1993.sp019504</ArticleId><ArticleId IdType="pmc">PMC1175248</ArticleId><ArticleId IdType="pubmed">8394422</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosier D.R., Baldelli P., Delbono O., Smith R.G., Alexianu S.E., Appel S.H., Stefani E. Amyotrophic lateral sclerosis immunoglobulins increase Ca2+ currents in a motoneuron cell line. Ann. Neurol. 1995;37:102&#x2013;109. doi: 10.1002/ana.410370119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410370119</ArticleId><ArticleId IdType="pubmed">7818241</ArticleId></ArticleIdList></Reference><Reference><Citation>Llin&#xe1;s R., Sugimori M., Cherksey B.D., Smith R.G., Delbono O., Stefani E., Appel S. IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayer. Proc. Natl. Acad. Sci. USA. 1993;90:11743&#x2013;11747. doi: 10.1073/pnas.90.24.11743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.90.24.11743</ArticleId><ArticleId IdType="pmc">PMC48060</ArticleId><ArticleId IdType="pubmed">8265620</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt J.I., Siklos L., Appel S.H. Altered calcium homeostasis and ultrastructure in motoneurons of mice caused by passively transferred anti-motoneuronal IgG. J. Neuropathol. Exp. Neurol. 1997;56:21&#x2013;39. doi: 10.1097/00005072-199701000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199701000-00003</ArticleId><ArticleId IdType="pubmed">8990126</ArticleId></ArticleIdList></Reference><Reference><Citation>La Bella V., Goodman J.C., Appel S.H. Increased CSF glutamate following injection of ALS immunoglobulins. Neurology. 1997;48:1270&#x2013;1272. doi: 10.1212/WNL.48.5.1270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.48.5.1270</ArticleId><ArticleId IdType="pubmed">9153455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ob&#xe1;l I., Klausz G., M&#xe1;ndi Y., Deli M., Sikl&#xf3;s L., Engelhardt J.I. Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-&#x3b1;, IL-6, and IL-10 in the spinal cord and serum of mice. J. Neuroinflamm. 2016;13:121. doi: 10.1186/s12974-016-0586-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0586-7</ArticleId><ArticleId IdType="pmc">PMC4879728</ArticleId><ArticleId IdType="pubmed">27220674</ArticleId></ArticleIdList></Reference><Reference><Citation>Milo&#x161;evi&#x107; M., Mili&#x107;evi&#x107; K., Bo&#x17e;i&#x107; I., Lavrnja I., Stevanovi&#x107; I., Bijeli&#x107; D., Dubai&#x107; M., Zivkovi&#x107; I., Stevi&#x107; Z., Giniatullin R., et al. Immunoglobulins G from Sera of Amyotrophic Lateral Sclerosis Patients Induce Oxidative Stress and Upregulation of Antioxidative System in BV-2 Microglial Cell Line. Front. Immunol. 2017;8:1619. doi: 10.3389/fimmu.2017.01619.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01619</ArticleId><ArticleId IdType="pmc">PMC5703705</ArticleId><ArticleId IdType="pubmed">29218049</ArticleId></ArticleIdList></Reference><Reference><Citation>Milo&#x161;evi&#x107; M., Stenovec M., Kreft M., Petru&#x161;i&#x107; V., Stevi&#x107; Z., Trkov S., Andjus P.R., Zorec R. Immunoglobulins G from patients with sporadic amyotrophic lateral sclerosis affects cytosolic Ca2+ homeostasis in cultured rat astrocytes. Cell Calcium. 2013;54:17&#x2013;25. doi: 10.1016/j.ceca.2013.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2013.03.005</ArticleId><ArticleId IdType="pubmed">23623373</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L., World Federation of Neurology Research Group on Motor Neuron Diseases El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel S.H., Engelhardt J.I., Garc&#xed;a J., Stefani E. Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction. Proc. Natl. Acad. Sci. USA. 1991;88:647&#x2013;651. doi: 10.1073/pnas.88.2.647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.2.647</ArticleId><ArticleId IdType="pmc">PMC50869</ArticleId><ArticleId IdType="pubmed">1988960</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosier D.R., Sikl&#xf3;s L., Appel S.H. Resistance of extraocular motoneuron terminals to effects of amyotrophic lateral sclerosis sera. Neurology. 2000;54:252&#x2013;255. doi: 10.1212/WNL.54.1.252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.54.1.252</ArticleId><ArticleId IdType="pubmed">10636164</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A.M. C9orf72-mediated ALS and FTD: Multiple pathways to disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall D., Baloh R.H. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J. Clin. Investig. 2017;127:3250&#x2013;3258. doi: 10.1172/JCI90607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90607</ArticleId><ArticleId IdType="pmc">PMC5669558</ArticleId><ArticleId IdType="pubmed">28737506</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudria-Lopez E., Koppers M., de Wit M., van der Meer C., Westeneng H.J., Zundel C.A., Youssef S.A., Harkema L., de Bruin A., Veldink J.H., et al. Full ablation of C9orf72 in mice causes immune system-related pathology and neoplastic events but no motor neuron defects. Acta Neuropathol. 2016;132:145&#x2013;147. doi: 10.1007/s00401-016-1581-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1581-x</ArticleId><ArticleId IdType="pmc">PMC4911370</ArticleId><ArticleId IdType="pubmed">27206760</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikl&#xf3;s L., Engelhardt J.I., Alexianu M.E., Gurney M.E., Siddique T., Appel S.H. Intracellular calcium parallels motoneuron degeneration in SOD-1 mutant mice. J. Neuropathol. Exp. Neurol. 1998;57:571&#x2013;587. doi: 10.1097/00005072-199806000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199806000-00005</ArticleId><ArticleId IdType="pubmed">9630237</ArticleId></ArticleIdList></Reference><Reference><Citation>Lips M.B., Keller B.U. Endogenous calcium buffering in motoneurones of the nucleus hypoglossus from mouse. J. Physiol. 1998;511:105&#x2013;117. doi: 10.1111/j.1469-7793.1998.105bi.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.1998.105bi.x</ArticleId><ArticleId IdType="pmc">PMC2231095</ArticleId><ArticleId IdType="pubmed">9679167</ArticleId></ArticleIdList></Reference><Reference><Citation>Palecek J., Lips M.B., Keller B.U. Calcium dynamics and buffering in motoneurones of the mouse spinal cord. J. Physiol. 1999;520:485&#x2013;502. doi: 10.1111/j.1469-7793.1999.00485.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.1999.00485.x</ArticleId><ArticleId IdType="pmc">PMC2269591</ArticleId><ArticleId IdType="pubmed">10523417</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanselow B.K., Keller B.U. Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneurone disease. J. Physiol. 2000;525:433&#x2013;445. doi: 10.1111/j.1469-7793.2000.t01-1-00433.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.2000.t01-1-00433.x</ArticleId><ArticleId IdType="pmc">PMC2269959</ArticleId><ArticleId IdType="pubmed">10835045</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Ho B.K., Sikl&#xf3;s L., Alexianu M.E., Mosier D.R., Mohamed A.H., Otsuka Y., Kozovska M.E., McAlhany R.E., Smith R.G., et al. Parvalbumin overexpression alters immune-mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. J. Neurochem. 2001;79:499&#x2013;509. doi: 10.1046/j.1471-4159.2001.00582.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2001.00582.x</ArticleId><ArticleId IdType="pubmed">11701753</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Bosch L., Van Damme P., Bogaert E., Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta. 2006;1762:1068&#x2013;1082. doi: 10.1016/j.bbadis.2006.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.05.002</ArticleId><ArticleId IdType="pubmed">16806844</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortarolo M., Grignaschi G., Calvaresi N., Zennaro E., Spaltro G., Colovic M., Fracasso C., Guiso G., Elger B., Schneider H., et al. Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease. J. Neurosci. Res. 2006;83:134&#x2013;146. doi: 10.1002/jnr.20715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.20715</ArticleId><ArticleId IdType="pubmed">16323214</ArticleId></ArticleIdList></Reference><Reference><Citation>Paizs M., Tortarolo M., Bendotti C., Engelhardt J.I., Sikl&#xf3;s L. Talampanel reduces the level of motoneuronal calcium in transgenic mutant SOD1 mice only if applied presymptomatically. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2011;12:340&#x2013;344. doi: 10.3109/17482968.2011.584627.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.584627</ArticleId><ArticleId IdType="pmc">PMC3231880</ArticleId><ArticleId IdType="pubmed">21623665</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripolszki K., Danis J., Padhi A.K., Gomes J., Boz&#xf3; R., Nagy Z.F., Nagy D., Kliv&#xe9;nyi P., Engelhardt J.I., Sz&#xe9;ll M. Angiogenin mutations in Hungarian patients with amyotrophic lateral sclerosis: Clinical, genetic, computational, and functional analyses. Brain Behav. 2019;9:e01293. doi: 10.1002/brb3.1293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1293</ArticleId><ArticleId IdType="pmc">PMC6576160</ArticleId><ArticleId IdType="pubmed">31025543</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa J., Swash M., de Carvalho M. Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: A systematic review. Arch. Neurol. 2012;69:1410&#x2013;1416. doi: 10.1001/archneurol.2012.254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2012.254</ArticleId><ArticleId IdType="pubmed">22892641</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum J.M., Stambler N., Malta E., Fuller C., Hilt D., Thurmond B., Nakanishi A. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) J. Neurol. Sci. 1999;169:13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgers M., De Brabander M., Van Reempts J., Awouters F., Jacob W.A. Intranuclear microtubules in lung mast cells of guinea pigs in anaphylactic shock. Lab. Investig. 1977;37:1&#x2013;8. doi: 10.3109/00365517709108795.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365517709108795</ArticleId><ArticleId IdType="pubmed">69052</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgers M. The role of calcium in the toxicity of the myocardium. Histochem. J. 1981;13:839&#x2013;848. doi: 10.1007/BF01003293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01003293</ArticleId><ArticleId IdType="pubmed">7298378</ArticleId></ArticleIdList></Reference><Reference><Citation>Adalbert R., Engelhardt J.I., Sikl&#xf3;s L. DL-Homocysteic acid application disrupts calcium homeostasis and induces degeneration of spinal motor neurons in vivo. Acta Neuropathol. 2002;103:428&#x2013;436. doi: 10.1007/s00401-001-0485-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-001-0485-5</ArticleId><ArticleId IdType="pubmed">11935257</ArticleId></ArticleIdList></Reference><Reference><Citation>Ob&#xe1;l I., Engelhardt J.I., Sikl&#xf3;s L. Axotomy induces contrasting changes in calcium and calcium-binding proteins in oculomotor and hypoglossal nuclei of Balb/c mice. J. Comp. Neurol. 2006;499:17&#x2013;32. doi: 10.1002/cne.21041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.21041</ArticleId><ArticleId IdType="pubmed">16958104</ArticleId></ArticleIdList></Reference><Reference><Citation>Paizs M., Engelhardt J.I., Katarova Z., Sikl&#xf3;s L. Hypoglossal motor neurons display a reduced calcium increase after axotomy in mice with upregulated parvalbumin. J. Comp. Neurol. 2010;518:1946&#x2013;1961. doi: 10.1002/cne.22312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.22312</ArticleId><ArticleId IdType="pubmed">20394052</ArticleId></ArticleIdList></Reference><Reference><Citation>Patai R., Paizs M., Tortarolo M., Bendotti C., Ob&#xe1;l I., Engelhardt J.I., Sikl&#xf3;s L. Presymptomatically applied AMPA receptor antagonist prevents calcium increase in vulnerable type of motor axon terminals of mice modeling amyotrophic lateral sclerosis. Biochim. Biophys. Acta Mol. Basis Dis. 2017;1863:1739&#x2013;1748. doi: 10.1016/j.bbadis.2017.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2017.05.016</ArticleId><ArticleId IdType="pubmed">28528135</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikl&#xf3;s L., Kuhnt U., P&#xe1;rducz A., Szerdahelyi P. Intracellular calcium redistribution accompanies changes in total tissue Na+, K+ and water during the first two hours of in vitro incubation of hippocampal slices. Neuroscience. 1997;79:1013&#x2013;1022. doi: 10.1016/S0306-4522(97)00031-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4522(97)00031-6</ArticleId><ArticleId IdType="pubmed">9219964</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxwell M.H. Two rapid and simple methods used for the removal of resins from 1.0 micron thick epoxy sections. J. Microsc. 1978;112:253&#x2013;255. doi: 10.1111/j.1365-2818.1978.tb01174.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2818.1978.tb01174.x</ArticleId><ArticleId IdType="pubmed">349160</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson K.C., Jarett L., Finke E.H. Embedding in epoxy resins for ultrathin sectioning in electron microscopy. Stain Technol. 1960;35:313&#x2013;323. doi: 10.3109/10520296009114754.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10520296009114754</ArticleId><ArticleId IdType="pubmed">13741297</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz-Orive L.M., Weibel E.R. Sampling designs for stereology. J. Microsc. 1981;122:235&#x2013;257. doi: 10.1111/j.1365-2818.1981.tb01265.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2818.1981.tb01265.x</ArticleId><ArticleId IdType="pubmed">7017151</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayat M.A. Principles and Techniques of Electron Microscopy: Biological Applications. 4th ed. Cambridge University Press; Cambridge, UK: 2000.</Citation></Reference><Reference><Citation>Reynolds E.S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J. Cell Biol. 1963;17:208&#x2013;212. doi: 10.1083/jcb.17.1.208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.17.1.208</ArticleId><ArticleId IdType="pmc">PMC2106263</ArticleId><ArticleId IdType="pubmed">13986422</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayhew T.M. A review of recent advances in stereology for quantifying neural structure. J. Neurocytol. 1992;21:313&#x2013;328. doi: 10.1007/BF01191700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01191700</ArticleId><ArticleId IdType="pubmed">1607876</ArticleId></ArticleIdList></Reference><Reference><Citation>Weibel E.R. Stereological Methods Vol. 1. Practical Methods for Biological Morphometry. Academic Press; London, UK: New York, NY, USA: Toronto, ON, USA: Sydney, Australia: San Francisco, CA, USA: 1979.</Citation></Reference><Reference><Citation>Domoki F., Bari F., Nagy K., Busija D.W., Sikl&#xf3;s L. Diazoxide prevents mitochondrial swelling and Ca2+ accumulation in CA1 pyramidal cells after cerebral ischemia in newborn pigs. Brain Res. 2004;1019:97&#x2013;104. doi: 10.1016/j.brainres.2004.05.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2004.05.088</ArticleId><ArticleId IdType="pubmed">15306243</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>